As outlined in Table 1, our results demonstrate that in PD, the expression of RHBDF2 and TNFRSF10B in brain regions such as the prefrontal cortex, substantia nigra, and thalamus shows no significant deviation from normal controls, indicating that they may not serve as specific markers for PD. This evidence concerns the gene RHBDF2 and Parkinson disease.